INTRODUCTION
The proliferation of normal human T cells in response to autologous non-T peripheral blood mononuclear cells, known as the autologous mixed lymphocyte reaction (AMLR),' may be involved in the regulation of immune responses (1, 2) . The cells responding in this reaction demonstrate immunological memory and specificity (3) . Although the responder cells in 'Abbreviations used in this paper: AMLR, autologous mixed lymphocyte reaction; Con A, concanavalin A; MLR, mixed lymphocyte reaction; PBC, primary biliary cirrhosis; SLE, systemic lupus erythematosus; SRBC, sheep erythrocytes. the AMLR are not cytotoxic for stimulating B cells or B lymphoid cell lines (4) , the responder cells may have cytotoxic potential against lipopolysaccharidestimulated autologous target cells (5) . Furthermore, it has been shown that cells proliferating in the AMLR may suppress proliferative and cytotoxic responses in secondary cultures (6) , and that the T cell subpopulation responding in the AMLR is enriched with cells that have the potential of becoming suppressor cells when activated by concanavalin A (Con A) (7) . Thus, the decreased generation of suppressor T cells (8) (9) (10) and the deficiency of the AMLR (11) (12) (13) , which have been found both in patients with systemic lupus erythematosus (SLE) and NZB mice, may be closely related abnormalities.
Recently, we have found that patients with primary biliary cirrhosis (PBC), a disease characterized by inflammatory necrosis of bile ducts and multiple immunological defects, have defective regulation of pokeweed mitogen-induced immunoglobulin synthesis (14) . In particular, T cells from patients with PBC do not inhibit immunoglobulin synthesis by autologous B cells at high T to B cell ratios (10:1) . Suppression of proliferative responses by Con A activated cells is also deficient in patients with PBC (15, 16) . The studies described here demonstrate that patients with PBC also have an impaired capacity to mediate an ANILR.
METHODS
Patients studied. 10 patients with PBC were studied at the Clinical Center of the National Institutes of Health.
Informed conisent was obtained from each patient. The study protocol had been approved by the National Institute of Arthritis, Metabolism and Digestive Diseases Clinical Research Subpanel. Each patient had typical clinical, serum biochemical, and serological features of PBC. In addition, liver biopsy from each patient showed histologic features compatible with PBC. Patients ranged in age from 39 to 66 yr, and one patient was male. Two patients had the sicca syndrome, but no patient had any other significant illness. One patient was taking D-penicillamine at the time of study. None of the other patients were taking antiinflammatory medications. 10 normal laboratory personnel, ranging in age from 31 to 47 yr, served as control subjects. In addition, three patients with idiopathic sclerosing cholangitis were studied as liver disease controls.
Cell preparations. Mononuclear cells were isolated from fresh heparinized venous blood by Ficoll-Hypaque (Lymphocyte Separation Medium, Bionetics Laboratory Products, Litton Bionetics, Inc., Kensington, Md.) density gradient centrifugation. In some experiments, mononuclear cells were separated into T and non-T fractions using Sephadex anti-(Fab')2 immunoabsorbant affinity columns as previously described (14) . In brief, mononuclear cells were passed over columns containing Sephadex G-200 to which purified rabbit anti-human (Fab')2 had been covalently bound. 60-80% of the cells in the first fraction eluted from the column formed rosettes with sheep erythrocytes (SRBC). Less than 1% were B cells as determined by staining with fluoresceinated anti-human light chain antibody ([Fab']2, prepared in our laboratory) and <1% of the cells were monocytes, as determined by their ability to ingest latex beads. This T cell enriched fraction was used as the responder cell fraction in one-way mixed lymphocyte reactions. A non-T cell enriched fraction was eluted from the columns using medium supplemented with human gamma globulin (Cohn fraction II, Miles Laboratories, Inc., Elkhart, Ind.). Of the cells in this fraction, on the average 45% were B cells, 40% were monocytes, and <1% T cells (SRBC rosette-forming cells). The composition of these cell fractions was similar for patients and normal subjects.
In some experiments, mononuclear cells were separated into T and non-T cell fractions by the formation ofspontaneous SRBC rosettes overnight at 40C, followed by centrifugation of the mixture over Ficoll-Hypaque and lysis of the rosettes with ammonium chloride buffer. In other experiments, as indicated below, stimulator cell fractions were depleted of cells that were adherent to plastic petri dishes. In yet other experiments, monocytes were isolated using the method of Beale et al. (17) . In brief, mononuclear cells were passed over a column of Sephadex G-10. Nonadherent cells were eluted with 100 cm3 of warm RPMI-1640 containing 20% fetal calf serum; this fraction was separated into T and non-T cell enriched fractions by formation of SRBC rosettes as described above. Adherent cells were removed from G-10 columns by transferring the column beads to medium without fetal calf serum, vigorous vortexing of the beads, and allowing the beads to sediment in an ice bath. This fraction was incubated overnight at 37°C in glass petri dishes, washed three times with warm medium to remove nonadherent cells, and incubated for 45 min at 40C with cold phosphate-buffered saline. This cell fraction contained -90% esterase positive cells. Stimulator cells were irradiated with 2,500 rad before culture by exposure to a 137Cs source (Gammator M, Isomedix, Inc., Parsippany, N. J.).
Cell cultures and measurement of [3H]thymidine incorporation. Cells were cultured in RPMI-1640 (Gibco Laboratories, Grand Island Biological Co., Grand Island, N. Y.) supplemented with 4 mM L-glutamine, 100 U/ml penicillin, 100 Ag/ml streptomycin, and 10% heat-inactivated human AB serum. In some experiments, this culture medium was further supplemented with heat-inactivated normal human serum or serum obtained from patients with PBC. Cells were cultured in flat-bottom microtest plates (No. 3040, Falcon Labware, Div. of Becton, Dickinson Co., Oxnard, Calif.) at 37°C in a 5% CO2 humidified atmosphere, using cell concentrations and duration of culture as described below. The final culture volume was 0.2 ml. 4.5 h before termination of culture, 0.5 ,uCi of methyl-[3H]thymidine (6.7 CilmM sp act, New England Nuclear, Boston, Mass.) was added to each culture. Samples were harvested using an automated sample harvester (Mash II, Microbiological Associates, Walkersville, Md.) and counted in a liquid scintillation counter. The number of disintegrations per minute per sample was calculated using internal standards. Cell cultures were performed in multiples of six. Geometric mean values (x/÷. SEM) were determined for appropriate groups of data, and the significance of differences between groups was determined using the Mann-Whitney test.
RESULTS
Comparison of the AMLR and MLR in patients with PBC and normal subjects. In our initial series of experiments, we determined values for the AMLR and the allogeneic MLR in patients with PBC and normal subjects using culture medium containing normal human serum. In preliminary experiments using normal lymphocytes, we found that maximal values for the AMLR occurred when non-T cell fractions eluted from anti-(Fab')2 immunoabsorbant columns and depleted of cells that were adherent to plastic were used as the stimulator cells. These stimulator cells plus responder T cells were cultured in equal numbers (1 x 105) for 6 d. The geometric mean value for the AMLR in 10 patients with PBC, 1,038 dpm, was significantly lower (P < 0.01) than that observed in 10 normal individuals, 9,013 dpm ( Fig. 1 ). In contrast, in the MLR the mean response of T cells from patients with PBC stimulated by normal allogeneic cells (117,993 dpm) was not significantly different from the mean response of normal T cells to stimulator cells obtained from patients with PBC (102,434 dpm) ( Fig. 1 ). In addition, in the MLR the response ofnormal T cells to allogeneic normal stimulator cells ( depletion from the non-T cell fraction of a stimulator subpopulation as a result of the method used to isolate the non-T fraction described above. Alternatively, the decreased AMLR in PBC patients might be due to the presence of cells within the non-T stimulator cell population that inhibit the AMLR. To investigate these possibilities, we used several different cell fractions as stimulator cells in the AMLR. As shown in Table I (experiments 1 and 2), the stimulatory capacity of PBC non-T cells was enhanced by preincubation of the stimulating cells on plastic; however, the increase was similar to the increase seen in normal individuals. When mononuclear cells were fractionated by SRBC rosette formation (Table I, (Table II) . However, the extent to which the AMLR and MLR were reduced by serum from other patients with PBC was similar. Since these experiments were carried out in medium which contained normal serum, the diminished incorporation of thymidine is not due simply to the inability of PBC sera to support the MLR or AMLR. These results demonstrate that although serum from patients with PBC may have an inhibitory effect on proliferative responses, the inhibitory effect is not specific for the normal AMLR.
The effect of the same normal and PBC sera on the AMLR and MLR oflymphocytes obtained from a patient with PBC was also determined. When 10% normal serum was added to the culture medium, the mean AMLR was 2,420 dpm (x/I 1.17, n = 8), and when 10% PBC serum was added, the mean AMLR was 574 dpm (x/. 1.37, n = 8). Similarly, the MLR of the patient with PBC was 74,267 dpm (x/÷ 1.03, n = 8) Responder T cells from one normal individual and stimulator cells (autologous and from one allogeneic normal donor) were prepared as in Fig. 1 (18) , and high levels of circulating immune complexes (19) . Recently, we have found that patients with PBC have decreased T cell-mediated inhibition of pokeweed mitogen-induced immunoglobulin synthesis in autologous cultures of T and B cells (14) . In addition, recent data suggest that Con A-induced suppressor T cell activity is reduced in PBC (15, 16 (7) . On the basis of these findings, it has been suggested that the AMLR reaction occurs in vivo and can play a role in feedback regulation of the immune response. Thus, an abnormal AMLR may contribute to abnormal regulation of the immune response and hence contribute to autoimmune phenomena seen in PBC.
We have previously shown that although T cells from patients with PBC have decreased ability to inhibit immunoglobulin synthesis by autologous B cells at high T to B cell ratios (10:1), they retain the ability to inhibit immunoglobulin synthesis by normal allogeneic B cells (14) . On the basis of this finding, we have suggested that patients with PBC may have a decrease in function of the population of T cells that is necessary for suppression in autologous cultures, but that the function of the population of T cells necessary for suppression in allogeneic cultuires is intact in PBC. The finding of a deficiency ofthe AMLR, but normal MLR, in patients with PBC supports this hypothesis and indicates that a deficiency of the AMLR may be the basis for the defect of suippressor T cell Deficiency of Autologouis AILR in Patietnts w itli Primiiary Biliary Cirrhosis function in autologous cultures. Further studies of the nature of the responder cell in the AMLR in patients with PBC is required to prove this hypothesis.
The mechanism by which a deficiency of the AMLR occurs in PBC is not known. The abnormality might be due to a decreased number of responder cells in the T cell population, to a deficiency of T cell recognition of the stimulator population, to a deficiency in the number of stimulator cells in the non-T cell population, or to an inherited or acquired alteration in the surface characteristics of the stimulator population. With regard to the nature of the stimulator cell, Kuntz et al. (2) have suggested that null cells are the major stimulator cells, while Sakane et al. (11) have provided evidence that B cells are the major stimulator cells. Recently, Beale et al. (17) using different techni(ues of cell isolation have shown that monocytes are the predominant stimulator cell type in the AMLR. Under the conditions used in our studies, we also found that the magnitude of the proliferative response in the AMLR was greatest when purified monocytes were used as the stimulators. With regard to the nature of the surface determinants on the stimulator cells, there is some evidence that the antigens responsible for the AMLR are closely related to the HLA-D locus (20) , as well as evidence that the antigens responsible for the AMLR are distinct from those responsible for the MLR (21). Kuntz et al. (12) have found that the AMLR in three patients with SLE was normal when stimulator cells were obtained from MLR identical normal siblings. This finding suggests that the defective AMLR which has been observed in SLE is due to an abnormality of the stimulator population, rather than a defect of the T cell population. Because patients with PBC have a number of immune abnormalities in common with patients with SLE, a similar mechanism might account for our findings in PBC, although other possibilities clearly must be excluded.
In conclusion, patients with PBC have a defective response in the AMLR. This defect may be related to the defect of generation of suppressor T cell activity which has previously been described in this disease. Further understanding of the mechanism by which the AMLR occurs in normal subjects and in patients with abnormal immune responses may provide further insight into the pathogenesis of this as well as other autoimmune diseases.
